Back
Madrigal Pharmaceuticals Vs. Matinas BioPharma Holdings Industry Stock Comparison
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
$308.99
Seasonality Move:
15.43%
Sell
22
MTNB
Matinas BioPharma Holdings
Last Price:
$0.54
Seasonality Move:
13.52%
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals [MDGL] share price is $308.71. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
-
The current Matinas BioPharma Holdings [MTNB] share price is $0.55. The Score for MTNB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
MTNB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $308.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.26 | Buy |
Relative Strength Index (14 RSI): | 51.24 | Buy |
Chaikin Money Flow: | 424640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (300.88 - 330.4) | Sell |
Bollinger Bands (100): | (218.15 - 309.67) | Buy |
MTNB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 31.02 | Sell |
Chaikin Money Flow: | -19914 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.56 - 0.62) | Sell |
Bollinger Bands (100): | (0.8 - 5.42) | Sell |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 303.23 | Buy |
20-day SMA: | 316.92 | Sell |
50-day SMA: | 288.91 | Buy |
200-day SMA: | 257.2 | Buy |
8-day EMA: | 304.61 | Buy |
20-day EMA: | 308.52 | Buy |
50-day EMA: | 294.35 | Buy |
200-day EMA: | 259.01 | Buy |
MTNB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Sell |
20-day SMA: | 0.59 | Sell |
50-day SMA: | 1.38 | Sell |
200-day SMA: | 6.37 | Sell |
8-day EMA: | 0.57 | Sell |
20-day EMA: | 0.66 | Sell |
50-day EMA: | 1.42 | Sell |
200-day EMA: | 5.65 | Sell |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.
Madrigal Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Matinas BioPharma Holdings Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |